Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys, Microsoft, Google, IBM, National Science Foundation, GeneGo, Biomax

Premium
Accelrys to Collaborate with Microsoft on Sharepoint Integration, HPC
 
Accelrys said this week that it is will support Microsoft's Office SharePoint Server 2007 as a “publication platform” for its scientific applications and that it will also collaborate with Microsoft to “evaluate” Windows HPC Server 2008 and other Microsoft products.
 
The collaboration “allows Accelrys to deliver scientific capabilities and content to the broader scientific community via their desktops," said Mark Emkjer, president and CEO of Accelrys, in a statement.
 
The integration with SharePoint Server will enable Accelrys’ applications to be executed and displayed from the SharePoint environment through SciTegic Enterprise Server 7.0.
 

 
NSF to Award $5M under ‘Cluster Exploratory’ Initiative
 
The National Science Foundation’s Computer and Information Science and Engineering directorate this week issued a solicitation for proposals for its new Cluster Exploratory, or CluE, initiative — a collaboration between Google, IBM, and NSF that aims to help researchers develop innovative methods for data-intensive computing.
 
NSF announced the CluE program, which is applicable to a range of scientific computing disciplines, including bioinformatics, in February [BioInform 02-29-08].
 
According to the initial solicitation, available here, NSF expects to award up to $5 million to between 10 and 15 awards. Selected projects will be funded up to $500,000, for durations of up to two years.
 
CluE will provide NSF-funded researchers access to software and services running on a Google-IBM cluster. The agency said it will allocate cluster computing resources for a “broad range of proposals” that will “explore the potential of this technology to contribute to science and engineering research and produce applications which promise to benefit society as a whole.”
 
Jeannette Wing, assistant director for CISE at NSF, said in a statement that the initiative is looking for projects that focus on data-intensive applications and "not cluster computing per se. We are not looking for scientific applications that are based primarily on solving massive numbers of partial differential equations since high-end computing resources are available for such research already."
 

 
Chinese University to Use GeneGo's MetaCore
 
GeneGo said this week that the Chinese University of Hong Kong’s Pediatric department has licensed its MetaCore pathway analysis platform.
 
GeneGo said that MetaCore’s broad coverage of biomarkers and drug targets for a large variety of diseases was a key factor in the university’s decision to license the database.
 
The deal represents GeneGo's first customer in Hong Kong, the company said.
 
Financial terms of the agreement were not provided.
 

 
Biomax Joins Austrian Personalized Medicine Consortium
 
Biomax Informatics said this week that it has been selected as a consortium partner in Austria’s OncoTyrol project Center for Personalized Cancer Medicine.
 
The four-year, €28 million ($43.7 million) OncoTyrol initiative focuses on “translating genomic, proteomic and metabolomic research into innovative, individualized and cost-effective approaches for cancer diagnosis and treatment,” Biomax said.
 
The company will provide its BioXM knowledge-management platform for the project.
 
"After an in-depth evaluation we concluded that the BioXM system, with its highly visual approach and outstanding data integration capabilities, is the backbone we need” for the project, Armin Graber, head of the institute for bioinformatics at the University for Health Sciences, Medical Informatics and Technology, and head of bioinformatics and system biology for the OncoTyrol initiative, said in a statement.
 
OncoTyrol comprises a consortium of researchers at the Biomedical Campus Innsbruck, the University Hospital Innsbruck, and other academic and industrial partners.

Filed under

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.